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In vivo and in organello footprinting techniques based
on methylation interference have been utilized to inves-
tigate protein-DNA interactions in the transcription ini-
tiation and rDNA transcription termination regions of
human mitochondrial DNA (mtDNA) in functionally ac-
tive mitochondria. In particular, the changes in methyl-
ation reactivity of these regions in response to treat-
ment of the organelles with ATP or ethidium bromide,
which affects differentially the rates of mitochondrial
rRNA and mRNA synthesis, have been analyzed. Two
major sites of protein-DNA interactions have been iden-
tified in the main control region of mtDNA, both in vivo
and in organello, which correspond to the regions of the
light-strand promoter and heavy-strand rRNA-specific
promoter. The in organello footprinting of the latter
showed ATP- and ethidium bromide-dependent modifi-
cations that could be correlated with changes in the rate
of rRNA but not of mRNA synthesis. By contrast, no ATP
effects were observed on the in organello footprinting
pattern of the termination region and on in vitro tran-
scription termination, strongly suggesting that ATP
control of rRNA synthesis occurs at the initiation level.
Several methylation interference sites were found up-
stream of the whole H-strand transcription unit, point-
ing to possible protein-DNA interactions related to the
activity of this unit. In vivo footprinting of the rDNA
transcription termination region of human mtDNA has
revealed a very strong protection pattern, indicating a
high degree of occupancy of the termination site by
mitochondrial transcription termination factor (;80%).
One of the hallmarks of the compact gene organization of
mammalian mtDNA is the location of most of the regulatory cis
elements in a restricted segment adjacent to the D-loop, which
contains the promoters for the transcription of the heavy (H)1-
and light (L)-strands and the origin of replication for the H-
strand (1). Mapping and kinetic analysis of in vivo synthesized
H-strand transcripts in HeLa cells (2–5) and in organello stud-
ies (6–8) have indicated that the mechanism of H-strand tran-
scription involves the activity of two overlapping, independ-
ently controlled transcription units starting at closely located
sites in the main control region, one covering the rDNA region
and the other the whole H-strand (9). The differential activity
of the two H-strand transcription units and an H-strand tran-
scription attenuation event at the 39-end of the 16 S rRNA gene
account for the fact that the rRNA genes and adjacent tRNA
genes are transcribed to a 20 to 50 times higher rate than the
downstream protein coding and tRNA genes (10). A central role
in the attenuation phenomenon mentioned above is played by
the mitochondrial transcription termination factor (mTERF), a
DNA-binding protein that protects a 28-base pair DNA seg-
ment immediately adjacent and downstream of the 16 S rRNA/
tRNALeu(UUR) boundary (11–13), which comprises a tridecamer
sequence critical for directing accurate termination (14).
Protein factors that bind to mtDNA in the main control
region (15, 16) and at the rDNA transcription termination site
(11–13) have been identified, and their interactions with DNA
have been investigated by DNase I protection footprinting as-
says using purified components (11, 15) and, more recently, by
applying on isolated organelles (17–20) and on intact cells (21,
22) the footprinting method of methylation interference
(23, 24).
Previous work carried out in our laboratory with a highly
efficient RNA-synthesizing system utilizing isolated HeLa cell
mitochondria (6–8) has shown that, in this system, the relative
transcription rates of rRNA and mRNA can be modulated in-
dependently by ATP (8) and by the intercalating drug EtBr (6).
In the present work, the changes in the relative rates of rRNA
and mRNA synthesis produced in response to ATP or EtBr
have been correlated with the patterns of protein-DNA inter-
actions in the transcription initiation and rDNA transcription
termination regions of mtDNA, as detected by analysis of meth-
ylation interference in cultured human cells or in organelles
isolated from HeLa cells. In particular, the significant ATP-
and EtBr-related modifications observed in the footprint of the
rRNA-specific promoter, which were specifically correlated
with changes in the rate of rRNA synthesis, have given support
to the model of two independently controlled overlapping H-
strand transcription units (9). Furthermore, no significant ATP
effect on rDNA transcription termination has been detected.
EXPERIMENTAL PROCEDURES
Cells and Culture Media—HeLa S3 cells were grown in suspension in
high phosphate-containing Dulbecco’s modified Eagle’s medium with
5% calf serum. The human cell line 143B.TK2 (25) was grown on solid
substrate in Dulbecco’s modified Eagle’s medium supplemented with
10% fetal calf serum.
Dimethyl Sulfate (DMS) Treatment of mtDNA in Intact Cells—Sam-
ples of 107 to 108 HeLa S3 cells or 3 3 106 143B.TK2 cells were routinely
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used. The methylation reaction, cell lysis, and total nucleic acid extrac-
tion were carried out as described previously (21). The yield of total
nucleic acids was 0.4 to 4.0 mg from each HeLa cell sample and ;200 mg
from each 143B.TK2 cell sample.
In Organello Methylation of mtDNA and RNA Synthesis—The mito-
chondrial fraction was isolated from 1.5 to 3.0 3 108 HeLa cells, essen-
tially as described previously (8), resuspended in incubation buffer (40
mM Tris-HCl, pH 7.4, 25 mM NaCl, 5 mM MgCl2, 10% glycerol) and
washed three times; the final pellet was then resuspended, at ;2
mg/ml, in incubation buffer containing 1 mg/ml bovine serum albumin,
10 mM NaH2PO4, 2.5 mM pyruvate, and the desired ATP or EtBr
concentration. For each incubation condition tested, two 500-ml samples
of the mitochondrial suspension were transferred into Eppendorf tubes,
and to one of them, destined for analysis of RNA synthesis, 10 mCi of
[a-32P]UTP (400 Ci/mmol) was added. One of the two tubes was incu-
bated at 37 °C under shaking for 20 min and the other for 30 min, and
then DMS treatment or, respectively, RNA extraction was performed on
the two samples, as detailed below. In particular, for DMS treatment,
26 ml of a freshly prepared 2% DMS solution in water was added to each
mitochondrial suspension incubated for 20 min and allowed to react for
2 min at 37 °C, and then 900 ml of ice-cold phosphate-buffered saline
was added, and the mitochondrial fraction was pelleted at 12,000 3 g
for 1 min. The DMS-treated mitochondrial fraction was washed three
times by centrifugation and resuspension in 1 ml of ice-cold phosphate-
buffered saline, resuspended in 400 ml of proteinase K buffer (10 mM
Tris-HCl, pH 7.5 (25 °C), 0.2 M NaCl, 0.1% SDS, 0.1 mg/ml proteinase
K) by vortexing, and incubated at room temperature for 30 min. The
sample was then extracted with phenol/chloroform/isoamyl alcohol (25:
24:1), and the nucleic acids were ethanol-precipitated as previously
detailed for in vivo DMS-treated samples (21). For each set of in or-
ganello footprinting experiments, a sample of the mitochondrial frac-
tion was treated identically, except for the omission of DMS treatment,
and DNA extracted from it for subsequent in vitro DMS treatment.
For analysis of the in organello transcription products, after the 30
min incubation, the mitochondrial samples were pelleted at 12,000 3 g
for 1 min, washed, dissolved in proteinase K buffer, and digested for 10
min at 37 °C. The samples were then phenol-extracted and ethanol-
precipitated; the RNA was electrophoresed on a 2.2 M formaldehyde,
1.4% agarose gel using MOPS buffer (20 mM MOPS, 10 mM sodium
acetate, 1 mM EDTA, pH 7.0, at 25 °C), and the RNA bands were
quantified, after drying the gel, using a PhosphorImager screen and
ImageQuant software (Molecular Dynamics).
In Vitro DMS Treatment of Naked DNA—The DNA methylation was
carried out on pellets containing about 200 mg of total nucleic acids
deriving from non-DMS-treated cells or 5–10 mg of nucleic acids from
untreated mitochondrial fractions as described elsewhere (21).
Piperidine Cleavage of DNA—This was performed on pellets contain-
ing approximately 200 mg of total nucleic acids from DMS-treated cells
or 5–10 mg of total nucleic acids from DMS-treated mitochondrial frac-
tions and on equivalent samples of in vitro DMS-treated total nucleic
acids from cells or isolated mitochondria, as described previously (21).
Primer Extension of DMS-treated DNA—The following oligode-
oxynucleotides, designated according to the numbering system of the
Cambridge sequence (26), were used for primer extension of DMS-
treated DNA in the assay as follows: L315, 59-CGCTTCTGGCCACAG-
CAC-39; L476, 59-CTAATCTCATCAATACAACC-39; H495, 59-GGTTG-
TATTGATGAGATTAG-39; and H719, 59-CTCACTGGAACGGGGATG-
39 for the fingerprinting of the initiation region; and L3064, 59-ATCT-
GAGTTCAGACCGG-39; and H3360, 59-TGCCATTGCGATTAGAATGG-
39 for the fingerprinting of the rDNA transcription termination region.
The oligodeoxynucleotides were 59-end-labeled with [g-32P]ATP as de-
tailed previously (21).
Five mg of DMS-treated and piperidine-cleaved total DNA from cells
(containing approximately 0.005 pmol of mtDNA) or 0.2–0.4 mg of
similarly treated DNA from the isolated mitochondrial fractions were
used as a template for primer extension analysis. Polymerase chain
reaction amplification and electrophoresis of the products through 6%
polyacrylamide, 7.7 M urea sequencing gels in Tris borate/EDTA buffer
were carried out as described previously (21).
DNA Binding Assays—The DNA binding activity of mTERF was
determined by mobility shift assays using the double-stranded 44-mer
oligodeoxynucleotide probe described previously (11). A constant
amount of mitochondrial lysate protein was incubated with 10 fmol of
probe in the presence of the indicated concentrations of ATP, and the
samples were then run on a native 5% polyacrylamide gel, as detailed
elsewhere (27).
In Vitro Transcription Termination and S1 Protection Assays—The
pTER plasmid, used as a template for the transcription termination
assays, has been previously described (11), as has been the clone
BSAND, utilized to synthesize the RNA probe employed in the S1
protection assays (12, 27). The transcription termination reactions and
the S1 protection assays were performed as detailed previously (12, 27);
quantification of the S1-resistant products was carried out by laser
densitometry of the autoradiogram.
RESULTS
Synthesis of RNA in Isolated HeLa Cell Mitochondria—Mi-
tochondria isolated from HeLa cells were incubated in the
presence of [a-32P]UTP in the appropriate buffer, as detailed
under “Experimental Procedures.” It has been previously
shown that HeLa cell mitochondria, under these conditions, are
able to carry out RNA synthesis in a way closely resembling the
in vivo process (6–8). In particular, transcription has been
shown to start at the two H-strand initiation sites (H1 for the
rDNA transcription unit, and H2 for the whole H-strand tran-
scription unit) and at the single L-strand initiation site, and
the transcripts have been shown to be processed in a way
reproducing the in vivo patterns; however, the relative rates of
rRNA synthesis and polyadenylation are somewhat reduced in
this in vitro system, as compared with the in vivo situation (7).
To determine the optimum time of DMS treatment for in
organello footprinting during mitochondria incubation, time
course and time interval pulse-labeling experiments were car-
ried out. Fig. 1a shows the electrophoretic patterns in an aga-
rose-formaldehyde gel of RNA labeled with [a-32P]UTP in iso-
lated HeLa cell mitochondria, in the presence of 1 mM ATP,
after different times of incubation or after different time inter-
val pulses. Fig. 1, b and c, shows the radioactivity incorporated
into total mitochondrial RNA, measured as overall signal from
gel-separated RNA bands scanned with a PhosphorImager, in
the continuous incorporation and, respectively, time interval
pulse-labeling experiments. From Fig. 1b it appears that the
accumulation of label into total mitochondrial RNA proceeds at
a fairly constant rate for 30 min at 37 °C. On the other hand,
the time interval pulse-labeling experiments, which tend to
exclude a possible role in the observed kinetics of changes in
RNA turnover rate during in vitro incubation, indicate that the
maximum rate of incorporation of radioactivity occurs between
10 and 30 min after the beginning of incubation and suggest a
fairly constant rate of incorporation up to 45 min. On the basis
of these experiments, DMS treatment for in organello foot-
printing was carried out 20 min from the start of incubation,
and the synthesized RNA was isolated at 30 min.
In Vivo and in Organello Footprinting of the L-Strand and
H-Strand Transcription Promoter Regions of HeLa Cell and
143B.TK2 Cell mtDNA—Fig. 2a shows the in vivo methylation
patterns of the H-strand in the L-strand transcription pro-
moter region of HeLa cell and 143B.TK2 cell mtDNA and the in
organello methylation pattern of the H-strand in the same
region of HeLa cell mtDNA (lanes E). By comparing these
patterns with those generated by DMS treatment of naked
DNA isolated from total cells or mitochondria (lanes N), one
recognizes regions of altered reactivity to DMS. In particular,
in the region around the L-strand initiation site (at position
;407), one H-strand residue (nucleotide 409), exhibits hyper-
methylation in the in vivo footprinting pattern, whereas five
H-strand residues (nucleotides 401, 403, 408, 409, and 410)
exhibit methylation protection or hypermethylation in the in
organello footprinting pattern. In the region spanning nucleo-
tides 418 to 447 upstream of the L-strand transcription initia-
tion site, which corresponds to the binding site of the mitochon-
drial transcription factor A (mTFA) (15), three H-strand
residues (nucleotides 427, 437, and 438) (Fig. 2a) and one
L-strand residue (nucleotide 429) (not shown) exhibit methyl-
ation protection, and one L-strand residue (nucleotide 443) (not
shown) hypermethylation in the in vivo footprinting pattern. In
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the in organello footprinting pattern, eight H-strand residues
(420, 427, 437, 438, 441, 444, 445, 446, and 447) (Fig. 2a) and
two L-strand residues (429 and 443) (not shown) exhibit meth-
ylation protection or hypermethylation in the same region. In
both the sequence immediately surrounding the L-strand tran-
scription initiation site and in the mTFA binding domain there
is a reasonable correspondence between the residues exhibiting
protection or hypermethylation in the in vivo and in the in
organello footprinting (;30 and 50% correspondence of resi-
dues showing methylation interference in the two regions).
Particularly noteworthy is the partial correspondence of hyper-
methylated nucleotides in vivo and in organello immediately
upstream of the L-strand transcription initiation site.
Fig. 2b shows the in vivo methylation patterns of the L-
strand in the regions of the H1 and H2 H-strand transcription
initiation sites of HeLa cell and 143B.TK2 cell mtDNA and the
in organello methylation pattern of the L-strand in the same
regions of HeLa cell mtDNA. The in vivo and in organello
methylation interference patterns in the L-strand of the region
of the rRNA-specific H-strand transcription initiation site H1
(at position ;559) and of the adjacent regions is shown with a
greater resolution in Fig. 2c after a longer electrophoretic run
of the same samples used in the experiment of Fig. 2b. In
particular, in the segment immediately surrounding the H1
initiation site, one L-strand residue (nucleotide 560) exhibits a
hypermethylation in the in vivo footprinting pattern (Fig. 2, b
and c); in the in organello footprinting pattern, the same resi-
due exhibits a much stronger hypermethylation (Fig. 2, b and
c), whereas one H-strand residue (nucleotide 557) shows meth-
ylation protection (not shown). In the mtDNA segment span-
ning nucleotides 524–546 upstream of the H1 transcription
initiation site, which corresponds to the mTFA binding site
(15), a single L-strand residue (nucleotide 545) exhibits meth-
ylation protection in the in organello footprinting pattern (Fig.
2, b and c). Within the segment between the mTFA binding site
and the H1 initiation site, two additional L-strand residues
(nucleotides 551 and 552) exhibit hypermethylation in the in
organello pattern (Fig. 2, b and c). Furthermore, in the segment
immediately downstream of the H1 start site, three L-strand
residues (nucleotides 577, 583, and 586) (Fig. 2, b and c) and
two H-strand residues (nucleotides 568 and 575) (not shown)
exhibit methylation protection in the in organello pattern.
The protection or hypermethylation phenomena described
above appear to occur at positions of known protein-DNA in-
FIG. 1. Labeling of RNA in isolated HeLa cell mitochondria
during continuous exposure or after different time interval ex-
posures to [a-32P]UTP. a, autoradiogram of formaldehyde-agarose gel
displaying RNA samples labeled for different times or after different
time interval pulses. b and c, quantification of total radioactivity incor-
porated into RNA, as determined from the overall signal obtained by
PhosphorImager scanning of the individual bands in the gel in the
continuous exposure experiment (b) or in the different time interval
pulse experiment (c). p-rRNAs, rRNA precursors (4); 12 S*, 12 S rRNA
precursor (7); 7 S, 7 S RNA; pCOI, COI mRNA precursor (43); COI,
COII, and COIII, mRNAs for cytochrome c oxidase subunits; ND1, ND2,
ND3, ND4, ND4L, and ND5, mRNAs for subunits of the respiratory
chain NADH dehydrogenase; Cyt b, mRNA for apocytochrome b; A6 and
A8, mRNAs for subunits ATPase 6 and ATPase 8 of the H1-ATPase.
FIG. 2. In vivo and in organello footprinting patterns of human
mtDNA L-strand (a) and H-strand (b and c) transcription pro-
moter regions. c shows the same samples of b, after a longer electro-
phoretic run, as well as the primer extension products of in vivo DMS-
treated total DNA from HeLa cells pretreated overnight with 0.125 mM
EtBr (H/EtBr). E, in vivo protected bands; l, in vivo hypermethylated
bands; M, in organello protected bands; f, in organello hypermethyl-
ated bands. N, naked DNA; E, experimental DNA.
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teractions (like those involving mTFA) or at potential sites of
similar interactions (involving RNA polymerase or transcrip-
tion factor(s)) at or near the RNA synthesis start positions. An
additional pattern of altered methylation reactivity was ob-
served in the L-strand in the segment spanning nucleotides
601–621 within the tRNAPhe gene, located about 40 nucleotides
downstream of the H1 transcription initiation site at position
;559. This mtDNA segment lies 27 nucleotides upstream of
the second H-strand transcription initiation site (H2 in Fig. 3)
near the 59-end of the 12 S rRNA gene. In particular, two
L-strand residues (nucleotides 620 and 621) are hypermethyl-
ated in the in vivo footprinting (Fig. 2b), and three L-strand
residues (nucleotides 601, 602, and 611) (Fig. 2b) and two
H-strand residues (nucleotides 602 and 609) (not shown) ex-
hibit altered methylation reactivity in the in organello pattern.
Fig. 3 summarizes the in organello and in vivo methylation
reactivity pattern of the L-strand and H-strand transcription
promoter regions.
Effect of ATP and EtBr on in Vivo and/or in Organello
Footprinting of the Promoter Regions—It has been previously
shown that the ATP requirements for rRNA synthesis and
mtDNA L-strand transcription in isolated HeLa mitochondria
are markedly different from those for mRNA synthesis (8). To
investigate whether ATP had any effect on the in organello
footprinting patterns, which could be correlated with changes
in transcription, isolated HeLa cell mitochondria were incu-
bated in different concentrations of ATP, ranging from 0 to 10
mM, and DMS treatment was performed 20 min after the be-
ginning of incubation. With due account for some differences in
the amount of sample loaded, no significant change in the in
organello footprinting pattern corresponding to the H-strand
(Fig. 4a) or L-strand (not shown) of the L-strand promoter was
observed in mtDNA from mitochondria incubated in different
ATP concentrations. By contrast, a clear-cut ATP-dependent
change was detected in the footprinting pattern of the H-strand
rDNA-specific promoter. In particular, the hypermethylated
L560 band exhibited a marked increase in intensity after ad-
dition of $0.25 mM ATP to the medium, reaching a maximum
between 1 and 5 mM, and declining at higher ATP concentra-
tions (Fig. 4b). Since the L560 band showed the most evident
change in intensity in relationship to ATP concentration, it was
utilized as an indicator of modifications in putative protein-
DNA interactions in subsequent experiments. It should be no-
ticed that the in organello methylation patterns obtained in the
presence of 1 mM ATP for the L-strand of the rDNA-specific
H-strand promoter and the H-strand of the L-strand promoter,
which are shown in Fig. 4, a and b, are substantially identical
to those observed in the independent experiment illustrated in
Fig. 2, a and b, indicating the reproducibility of the in organello
patterns.
Fig. 4c shows the patterns in a formaldehyde-agarose gel of
RNA labeled in isolated HeLa cell mitochondria in the presence
of different concentrations of ATP. It is clear that, in the ab-
sence of added ATP, the mRNA species are labeled to a sub-
stantial extent, whereas there is only marginal labeling of the
rRNA species; by contrast, addition of ATP at $0.25 mM
strongly stimulates rRNA synthesis, which reaches a maxi-
mum (including the rRNA precursors) at about 1 mM, with only
a moderate increase in mRNA synthesis. Fig. 4d correlates the
ATP-related changes in intensity of the L560 band with the
variations of the in organello rate of synthesis of 16 S rRNA
and mitochondrial mRNAs (ND5, ND4/4L, COI, Cytb, A6/8,
COIII, and COII). It is clear that the changes in level of meth-
ylation of the L560 band follow much more closely the modifi-
cations in rate of synthesis in organello of rRNA than the
changes in mRNA synthesis.
It has been previously shown (6) that, in isolated HeLa cell
mitochondria, intercalating drugs, like EtBr, inhibit preferen-
tially rRNA synthesis over mRNA synthesis. Such behavior is
clearly shown in the experiment illustrated in Fig. 4e. To in-
vestigate the possible occurrence of EtBr-induced changes in
the in organello footprinting patterns of the L-strand and H-
strand transcription promoter regions, isolated HeLa cell mi-
tochondria were incubated in the appropriate buffer containing
1 mM ATP in the presence of different concentrations of the
drug and then DMS-treated 20 min after the beginning of
incubation. A progressive decrease in methylation interference
of the H-strand footprinting pattern of the L-strand transcrip-
FIG. 3. Summary of in vivo and in organello methylation interference patterns of human mtDNA L-strand and H-strand tran-
scription promoter regions. Symbols are as in Fig. 2. L, L-strand; H1 and H2, H-strand transcription start sites; underlined are the
octanucleotide motifs at or near these sites.
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tion promoter (at the sites indicated by arrows in Fig. 4a) and
of the L-strand footprinting pattern of the same promoter (not
shown) was observed with increasing EtBr concentrations. In
the H-strand transcription promoter region, the hypermethyl-
ated band L560 again exhibited the most pronounced changes,
in relationship to the EtBr concentration, decreasing progres-
sively in intensity with increasing doses of the drug (Fig. 4b).
That these changes reflected a phenomenon occurring in vivo
was shown by the finding that a clear decrease in the hyper-
methylation of L560 was also observed by in vivo footprinting
in HeLa cells exposed to 0.125 mM EtBr (Fig. 2c). Fig. 4f corre-
lates the changes in intensity of the L560 band in the footprint-
ing patterns obtained from isolated HeLa cell mitochondria
incubated in the presence of different EtBr concentrations with
the variations in labeling of 16 S rRNA and mRNAs (ND5,
ND4/4L, COI, Cytb, A6/8, COIII, and COII) synthesized in
organello under the same conditions. It is apparent that the
intensity of the L560 band and the amount of labeled 16 S
rRNA decrease in a parallel way over the range of EtBr con-
centrations utilized, whereas the labeling of the mRNAs re-
mains essentially constant in the presence of EtBr up to 1 mM
and decreases moderately at 1.5 mM.
In Vivo and in Organello Footprinting of the Mitochondrial
rDNA Transcription Termination Region of HeLa and
143B.TK2 Cells and Effects of EtBr—Fig. 5, a and b (panels
labeled HeLa), shows the in vivo methylation patterns of the
L-strand and, respectively, H-strand of the HeLa cell mitochon-
drial rDNA transcription termination region, which is the site
of interaction of mTERF with DNA (11, 12). The mtDNA seg-
ment extending from nucleotide 3235 to nucleotide 3250, which
is entirely comprised within the region protected by mTERF
from DNase I digestion, exhibits several sites of methylation
protection or hypermethylation in the in vivo footprinting pat-
tern. In particular, three L-strand residues (nucleotides 3235,
3236, and 3244) are hypermethylated, and five L-strand resi-
dues (nucleotides 3238, 3239, 3242, 3248, and 3249) and three
FIG. 4. Effects of increasing concen-
trations of ATP and EtBr on the in
organello footprinting patterns of
the H-strand of the L-strand pro-
moter region and of the L-strand of
the H-strand promoter region, and on
RNA synthesis during incubation of
isolated HeLa cell mitochondria. a
and b, footprinting patterns of H-strand
of L-strand promoter region (a) and of
L-strand of H-strand promoter region (b)
(N, naked DNA). c and e, autoradiograms
of formaldehyde-agarose gels displaying
RNA samples labeled in isolated mito-
chondria for 30 min in the presence of the
indicated concentrations of ATP (c) or
EtBr (e). Symbols are as in Fig. 1. d and f,
quantification by PhosphorImager analy-
sis of the L560-hypermethylated band
(from b), expressed as percent relative to
the value for the naked DNA control, and
of the 16 S rRNA band and mRNA bands
(ND5, ND4/4L, COI, Cytb, A6/8, COIII,
and COII) (from c and e), expressed in
arbitrary units. f, L560 band; l, 16 S
rRNA; M, mRNAs.
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H-strand residues (nucleotides 3245, 3246, and 3247) exhibit
methylation protection. Fig. 5c shows the in vivo footprinting
pattern of the L-strand of the termination region in HeLa cells,
in a repeat independent methylation experiment, and in
143B.TK2cells. It is apparent that the in vivo footprinting
pattern is quite reproducible.
To analyze the effect of EtBr on the in vivo footprinting of the
mitochondrial rDNA transcription termination region, HeLa
cells were pretreated overnight with the drug at 0.125 mM. As
shown in Fig. 5, a and b (panels labeled HeLa/EtBr), the
methylation interference pattern of the binding site of mTERF
changed dramatically under these conditions. Among the L-
strand residues which were affected in their methylation in the
absence of the drug (Fig. 5a, HeLa), only three exhibited meth-
ylation interference in the ethidium bromide-treated cells. In
particular, L-strand residues 3235 and 3244 remained hyper-
methylated, and the protected L-strand nucleotide 3242 be-
came hypermethylated (Fig. 5a, HeLa/EtBr). The protection of
H-strand residues 3245, 3246, and 3247 (Fig. 5b, HeLa) all but
disappeared in the presence of EtBr. By contrast, the H-strand
residue 3240 became strongly hypermethylated (Fig. 5b,
HeLa/EtBr). It appears that the in vivo methylation interfer-
ence pattern of the rDNA transcription termination region,
after treatment of the cells with a low concentration of EtBr,
became in general more similar to the pattern obtained with
naked DNA. This effect pointed to a decrease, and probably a
modification, in the binding of mTERF to mtDNA, which pre-
sumably caused a reduction in its transcription termination
activity.
To investigate the effect of EtBr on the in organello footprint-
ing of the HeLa cell rDNA transcription termination region,
isolated organelles were exposed to various concentrations of
the drug. Fig. 5d shows the in organello methylation patterns
of the L-strand of that region. The naked DNA methylation
pattern in the segment between nucleotides 3230 and 3250
shows a general similarity to that obtained for DNA extracted
from whole cells (Fig. 5, a and c). However, there are some
differences in the identity, type of methylation interference,
and relative abundance of the methylated residues, as com-
pared with the pattern obtained for naked DNA extracted from
whole cells. These differences are possibly related to changes in
the structure of mtDNA (conversion of supercoiled to open
circular form?), that may have occurred during the isolation
and incubation of the organelles and thereby affected the meth-
ylation efficiency of DMS or possibly the pausing of Taq polym-
erase (20). Despite these differences in the reference DNA
pattern, the in organello methylation interference pattern ob-
tained after incubation of the organelles in the absence of EtBr
(i.e. under the standard conditions for in organello footprinting)
(Fig. 5d) shows a substantial similarity to the in vivo pattern,
with ;50% correspondence of the residues exhibiting protec-
tion or hypermethylation. Likewise, the footprinting pattern
obtained in the absence of EtBr for the H-strand of the termi-
nation region is reasonably similar to the in vivo pattern (not
shown).
Fig. 5e summarizes the in vivo DMS reactivity pattern, as
well as the in organello footprinting pattern, of the rDNA
transcription termination region. The percentage of protection
at several nucleotides, after correction for the difference in
loading of the lanes, ranged from 60% (nucleotide 3242) to 82%
(nucleotides 3248 and 3250).
After exposure of the isolated mitochondria to 0.5 and 1.0 mM
EtBr, there is a progressive decrease in the hypermethylation
of L-strand residues 3235, 3236, and 3245 and a progressive
decrease in the protection of L-strand residues 3238, 3242,
3243, 3248, and 3250 (Fig. 5d). As a result of these changes, the
methylation pattern of the L-strand tends to become more
similar to that of the naked DNA, as already observed for the in
vivo footprinting in the presence of EtBr (Fig. 5a). This tend-
ency, therefore, also points to a decreased binding of mTERF to
mtDNA in the presence of EtBr.
Lack of ATP Effects on in Organello Footprinting of HeLa
Cell Mitochondrial rDNA Transcription Termination Region—
The experiments described in a previous section, which corre-
lated the effects of ATP on the in organello footprinting of the
H-strand transcription promoter region with those on the syn-
thesis of RNA in isolated organelles (Fig. 4d), did not exclude
the possibility that ATP acted at the level of termination of
FIG. 5. In vivo and in organello footprinting of the HeLa cell
mitochondrial rDNA transcription termination region and ef-
fects of EtBr. a and b, in vivo methylation interference patterns of the
L-strand (a) and H-strand (b) of the termination region from untreated
HeLa cells (HeLa) or from cells treated overnight with 0.125 mM EtBr
(HeLa/EtBr). c, in vivo methylation interference patterns of the L-
strand of the termination region in a repeat independent experiment
with HeLa cells as in a and in an experiment with 143B.TK2 cells. d,
effects of increasing concentrations of EtBr on the in organello foot-
printing pattern of the L-strand of the termination region from HeLa
cells. The symbols represent the methylation interference pattern of the
sample not treated with EtBr. e, summary of in vivo (from a and b) and
in organello (from the pattern for 0 EtBr in d and the pattern for 1 mM
ATP in Fig. 6b) methylation interference patterns of L-strand and
H-strand of the mitochondrial rDNA transcription termination region.
Symbols are as in Fig. 2.
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mitochondrial rDNA transcription. To obtain evidence on this
possibility, the ATP effects on in organello footprinting of the
termination region were analyzed. Fig. 6, a and b, illustrates
the in organello methylation patterns of the L-strand and,
respectively, H-strand of the termination region after incuba-
tion of the organelles in the presence of various concentrations
of ATP. It should be noted that the L-strand pattern obtained
in the presence of 1 mM ATP (i.e. under our standard conditions
of in organello footprinting) is almost identical to that observed
in the independent methylation experiment in the absence of
EtBr shown in Fig. 5d, pointing again to the reproducibility of
the in organello methylation interference pattern. The most
significant result of the experiments shown in Fig. 6, a and b,
is the absolute identity of the methylation patterns obtained for
both the L- and H-strands after incubation of the organelles in
the presence of concentrations of ATP varying between 0 and
8–10 mM. These observations argue against the possibility of
an ATP effect at the level of transcription termination.
Lack of ATP Effects on in Vitro mTERF Binding to DNA and
Transcription Termination—Further evidence against a role of
ATP in transcription termination was provided by experiments
in which the effects of ATP on in vitro mTERF binding to DNA
(Fig. 6c) and on in vitro transcription termination (Fig. 6d)
were analyzed. As shown in Fig. 6c, mTERF binding to DNA, as
measured by band shift assays, was only marginally increased
in the presence of ATP concentrations from 0.5 to 5.0 mM, as
compared with no ATP, and slightly more at 10 mM ATP. As
illustrated in Fig. 6d, the proportion of terminated transcripts
in an in vitro reaction remained about 10% over the whole
range of ATP concentrations from 0.1 to 4 mM. Concentrations
higher than 4 mM inhibited almost completely the transcription
activity in our in vitro system (42).
DISCUSSION
Technical Aspects—DMS is known to methylate guanine res-
idues at the N-7 position and, with a lower frequency, adenine
at positions N-3 and N-7. It can also methylate adenine at
position N-1 and cytosine at position N-3 in single-stranded
DNA (28). Thymine can also be methylated at N-3 in single-
stranded DNA, but, being a much weaker base than cytosine,
its alkylation would be expected to occur in alkaline solution;
however, there are reports of alkylation of thymine at neutral
pH (28).
In the present work, although the majority of methylation
reactivity changes were observed at purine sites, a few pyrimi-
dines also showed an altered methylation pattern, in particu-
lar, in almost all cases, a hypermethylation. The methylation of
cytosine residues in vivo or in organello could be explained by
the occurrence of single-stranded DNA segments at those sites
as a result of helical distortions caused by protein binding (20,
29–31) or by RNA polymerase pauses (32, 33). However, since
piperidine does not cleave effectively the DNA chains at the
methylated cytosine sites, it is likely that Taq polymerase
pauses created fragments ending at those sites. Effective ter-
mination of primer extension by Taq polymerase at modified
bases has been recently demonstrated (20). In the case of thy-
mine, it seems possible that the alkaline environment of the
mitochondrial matrix would favor the methylation of this base.
In previous work on in organello footprinting of mammalian
mtDNA by DMS interference, evidence was reported for the
presence of methylated thymine residues in single-stranded
mtDNA segments (20), as well as for methylated cytosine res-
idues (18).
In the present study, the in organello footprinting patterns of
the transcription initiation and rDNA transcription termina-
tion regions of human mtDNA showed a substantial similarity
to the in vivo footprinting patterns, as concerns the location of
the mtDNA segments exhibiting methylation interference.
These included, in particular, the L-strand and H1 H-strand
transcription start sites, the mtDNA regions upstream of the
L-strand and of the H2 H-strand transcription start sites, and
the transcription termination region. However, in each seg-
ment, there were differences in the identity, type of methyla-
tion interference, and relative abundance of residues exhibiting
protection or hypermethylation. The reason for these differ-
ences is not known, but they were quite reproducible in inde-
pendent methylation experiments. They probably reflect small
variations in the protein-DNA contact sites due to DNA or
protein conformational changes. These may occur during the
isolation or incubation of mitochondria as a result of modifica-
tions in the internal environment of the organelles or of the
presence of additional components interacting with DNA or
with the DNA-binding factors (11, 34). Despite these varia-
tions, it is reasonable to assume that the fundamental protein-
DNA interactions underlying the methylation reactivity of
mtDNA in isolated organelles reflect those occurring in vivo.
This conclusion is supported by the close similarity between the
RNA synthesis pattern obtained, under the same conditions
utilized for in organello footprinting, in mitochondria isolated
from HeLa cells, and the in vivo pattern (6–8, and the present
work), and by the comparable EtBr effects on the methylation
interference patterns in vivo and in organello in the mtDNA
transcription initiation and termination regions.
Evidence for Protein-DNA Interactions at the L-strand and
FIG. 6. ATP effects on in organello footprinting of HeLa cell
mitochondrial rDNA transcription termination region and on in
vitro mTERF binding to DNA and termination promoting activ-
ity. a and b, in organello methylation interference patterns of L-strand
(a) and H-strand (b) of HeLa cell mtDNA in the presence of different
concentrations of ATP (N, naked DNA). Symbols as in Fig. 2. c, effect of
ATP on in vitro mTERF binding to DNA (O, no mTERF present). d,
transcription termination in vitro (R, run-off transcripts; T, terminated
transcripts; ND, not detectable).
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H1 H-strand Transcription Start Sites—In previous work, the
in organello footprinting patterns, as determined by methyla-
tion interference, of the promoter regions of mtDNA have been
analyzed in mitochondria from bovine brain (17), human pla-
centa (18), and rat liver (20). Methylation reactivity changes
were observed in the mtDNA region upstream of the L-strand
transcription start site and other changes, although consider-
ably weaker, in the region upstream of the H1 H-strand tran-
scription start site; these regions correspond to the mTFA
binding domains (15). The observations reported here on the in
vivo and in organello footprinting of the L-strand promoter
region agree with the above-mentioned findings. By contrast,
almost no nucleotide with altered methylation reactivity was
found in the mTFA binding region of the H1 H-strand promoter.
However, it should be noted that the present results are con-
sistent with the evidence indicating a much lower affinity of
mTFA for binding in vitro at the H1 H-strand promoter, as
compared with the L-strand promoter (15).
A significant observation made in the present work is the
presence of hypermethylated nucleotides, both in vivo and in
organello, at or very near the L-strand and the H1 H-strand
transcription start sites. It is interesting that, at both sites, the
hypermethylated nucleotides occur in the non-template strand.
In previous in organello footprinting studies, a weak hyper-
methylation of the non-template strand had also been observed
at the L-strand and H1 H-strand transcription initiation sites
in human placenta mtDNA (18). No such DMS hypersensitivity
near the RNA start sites had, on the contrary, been reported in
the in organello footprinting analysis of bovine brain (17) and
rat liver mtDNA (20). A possible explanation of this discrep-
ancy is the difference in nucleotide context of the transcription
start sites in human versus bovine or rat mtDNA. Earlier
investigations utilizing deletion analysis and site-specific mu-
tagenesis had identified sequence elements absolutely neces-
sary for transcription around the transcription start sites in
human mtDNA (35, 36). It should be mentioned, in this con-
nection, that the L-strand and H1 H-strand transcription start
sites are surrounded by the octanucleotide consensus sequence
ACC–CCAAA (underlined in Fig. 3) (35, 37) and that the ho-
mologous sites in Xenopus laevis mtDNA are also surrounded
by an octanucleotide consensus sequence, although different
(38). These findings had suggested possible protein-DNA inter-
actions at these sites. However, the present observations pro-
vide the first clear evidence of local DNA conformational
changes or increases in reagent concentration in hydrophobic
pockets, due to protein-DNA interactions, at these sites (39).
Since the in vivo and in organello hypermethylated residues at
both the L-strand and the H1 H-strand transcription start sites
were exclusively (in vivo) or mostly (in organello) Cs, it is
possible that these sites contain single-stranded DNA seg-
ments as a result of helical distortions caused by protein bind-
ing to DNA, a situation required for transcription activity.
Correlation of L-560 DMS Reactivity with ATP- and EtBr-
dependent Changes in Rate of 16 S rRNA Synthesis in Isolated
Mitochondria—The main observation reported in the present
work is that the changes in degree of in organello hypermethyl-
ation of L-560 at the H1 H-strand transcription initiation site
detected in response to either ATP or EtBr followed closely the
variation in rate of 16 S rRNA synthesis but not the variation
in rate of mRNA synthesis. This observation supported the
earlier strong evidence indicating that rRNA and mRNA syn-
thesis are independently controlled in mammalian mitochon-
dria (7, 8, 40). Furthermore, in view of the lack of influence of
ATP on transcription termination, which has been observed in
the present work, the results obtained on the ATP effects
corroborated the idea that the regulation by ATP of rRNA
synthesis occurs mainly, if not exclusively, at the level of ini-
tiation. It is particularly relevant to mention here that a spe-
cific requirement for ATP at an early step of in vitro transcrip-
tion of the rDNA of human mtDNA has been previously
documented (41). A regulatory role of ATP in mitochondrial
RNA synthesis in mammalian cells has been recently proposed
(42).
Methylation Interference Upstream of the H2 H-strand Tran-
scription Start Site—Another significant finding made in the
present work is the occurrence of in vivo hypermethylated
nucleotides and in organello protected or hypermethylated res-
idues in a ;20-base pair segment within the tRNAPhe gene,
which was not previously analyzed by others for in organello
footprinting and which is located 27 base pairs upstream of the
second in vivo H-strand transcription start site (H2 in Fig. 3).
This site has been identified in this laboratory at the 59-end of
the 12 S rRNA gene (3, 9), whereas others have positioned it
within the ACCCC at nucleotides 636–640 (37). It is particu-
larly interesting that the latter assigned position for the second
H-strand transcription start site lies within the octanucleotide
ACCCCATA (underlined in Fig. 3), which exhibits a seven of
eight nucleotide match to the consensus sequence mentioned
above (36). The results obtained here, which point to protein-
DNA interactions upstream of this transcription initiation site,
provide support to the strong evidence from in vivo and in
organello studies that indicate the existence of two overlap-
ping, independently controlled H-strand transcription units in
human mtDNA (3, 4, 6–9).
High in Vivo Occupancy of mTERF Binding Sites—The in
vivo footprinting pattern of the mitochondrial rDNA transcrip-
tion termination region observed in the present work in HeLa
cells was nearly identical to the in organello footprinting pat-
tern of the same region previously obtained from bovine brain
(17) and rat liver (20). In this pattern, the nucleotides with
altered reactivity are within the tridecamer sequence previ-
ously shown to be required for accurate transcription termina-
tion (14), with the exception of the two hypermethylated G
residues which flank this tridecamer on the 59-end side of the
L-strand. In view of the fact that the tridecamer sequence is a
recognition site for mTERF and is completely comprised within
the DNA binding domain for this factor (11), it is reasonable to
assume that the observed footprint of the rDNA transcription
termination region is caused by the binding of mTERF. Re-
markable is the pronounced asymmetry in the distribution
between the two strands of the residues with altered DMS
reactivity. These occur predominantly in the non-template L-
strand, pointing to a higher affinity of mTERF for this strand.
It is possible that this asymmetry is significant for the function
of mTERF, in connection with the modulation of its activity
that is required for the transcription of the downstream genes
(11). The high proportion of in vivo occupancy of binding sites
for mTERF in HeLa cell mtDNA, as estimated from the per-
centage of protection from methylation by DMS of the residues
in the footprinting pattern (up to about 80% for several nucle-
otides), is in agreement with the observations made by in
organello footprinting of the rDNA transcription termination
region in bovine brain and rat liver mitochondria (17, 20).
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